Youth Risk Behavior Survey (YRBS) Overview
This video explains how the information collected from YRBS can be used to help students make healthy choices to become healthy adults.
This video explains how the information collected from YRBS can be used to help students make healthy choices to become healthy adults.
The Youth Risk Behavior Survey (YRBS) is administered to high school students in grades 9-12 every other year. YRBS collects important information about high school students’ behaviors and experiences anonymously and voluntarily.
On June 18, 2022, the Office of Infectious Disease and HIV/AIDS Policy (OIDP) held a roundtable discussion in Miami, Florida, to launch the new national HIV viral suppression campaign, I am a Work of ART. The discussion was moderated by Harold Phillips, Director, White House Office of National AIDS Policy and panel members included the creative partners featured in the campaign materials. During the launch, attendees heard the creative partners tell their stories of being diagnosed with HIV, getting connected to care, and becoming virally suppressed.
This video provides information on how TB is spread. The video also explains how you can prevent the spread of TB.
This video discusses how any new prisoner to the country’s 17 penitentiaries sees a psychiatrist, a doctor and if needed is offered to join a treatment programme. Comprehensive harm reduction services not only include drug dependence treatment but also needle syringe exchange and HIV testing and treatment. HIV prevalence is 11% among people who inject drugs in Moldova vs 0.36% among the general population. They are one of the most affected groups in the country. UNAIDS, UNODC and WHO have been long-time supporters of expanding these services to all prisons.
This video discusses how Daouda Diouf comes daily to the Fann Hospital compound daily in Dakar, Senegal. He is one of 250 people enrolled in CEPIAD’s opioid substitution therapy programme (OST). OST is a globally recognized intervention to reduce injecting behaviors that put people who inject drugs at risk of contracting HIV and other blood-borne diseases, such as viral hepatitis.
One of four pre-recorded video presentations on the current landscape of U.S. government-supported mpox research. The highlighted research efforts include Phase III clinical trials of tecovirimat (TPOXX) to treat mpox.
A video summary on mpox research and development in the field of diagnostics conducted by the U.S. government.
A video summary of current scientific studies conducted by U.S. government agencies on mpox vaccine effectiveness, safety, equity, and development.
A video summary of current scientific studies conducted by U.S. government agencies on mpox surveillance and population science.